Publications

Publications

Research Papers

1. Sarita Maurya, Manish Gaur, Mohd. Sohail Akhtar* and Awadh Bihari Yadav*. Evaluation of Drug-Loaded and Surface-Adsorbed DNase/Tween-80 Solid Lipid Nanoparticles against Staphylococcus aureus Biofilms. https://doi.org/10.1021/acsabm.3c00887. ACS Applied Bio Materials, 2024; Accepted (Impact Factor 4.7)

2. Maurya, S., Gaur, M. & Yadav, A.B. Staphylococcus aureus Biofilm Destabilization by Tween-80 and Lung Surfactants to Overcome Biofilm-Imposed Drug Resistance. Appl Biochem Biotechnol (2023). https://doi.org/10.1007/s12010-023-04650-3 (Impact Factor: 3.0) 

3. Vancha Harish, M.M. Ansari, Devesh Tewari, Awadh Bihari Yadav* , Neelesh Sharma, Sweta Bawarig, María-Luisa García-Betancourt, Ali Karatutlu, Mikhael Bechelany, Ahmed Barhoum*, Cutting-edge advances in tailoring size, shape, and functionality of nanoparticles and nanostructures: A review. Journal of the Taiwan Institute of Chemical Engineers; Volume 149, August 2023, 105010: https://doi.org/10.1016/j.jtice.2023.105010 (Impact Factor: 5.4)  

4. Manish Gaur, Sarita Maurya, Mohd. Sohail Akhtar* and Awadh Bihari Yadav*. Synthesis and evaluation of BSA-loaded PLGA-chitosan composite nanoparticles for the protein-based drug delivery system. ACS Omega 2023, 8, 21, 18751–18759, https://doi.org/10.1021/acsomega.3c00738 (Impact Factor: 4.1)

5. Yadav, Preeti, Awadh Bihari Yadav, Preksha Gaur, Vartika Mishra, Zul-I Huma, Neelesh Sharma, and Young-Ok Son. 2022. "Bioengineered Ciprofloxacin-Loaded Chitosan Nanoparticles for the Treatment of Bovine Mastitis" Biomedicines 10, no. 12: 3282. https://doi.org/10.3390/biomedicines10123282 (Impact Factor: 4.7).

6. Vancha Harish, Md Mustafiz Ansari 1 , Devesh Tewari 2 , Manish Gaur 3 , Awadh Bihari Yadav 3 , María Luisa García-Betancourt 4 , Fatehy M. Abdel-Haleem 5,6 , Mikhael Bechelany 7, * and Ahmed Barhoum 8,9, *. Review on Nanoparticle and Nanostructure Synthesis and Controlled Growth Methods. Nanomaterials 2022, 12, x. https://doi.org/10.3390/xxxxx (Impact Factor: 5.7).

7. Vancha Harish 1, Devesh Tewari 1, Manish Gaur 2, Awadh Bihari Yadav 2, *, Shiv Swaroop 3, Mikhael Bechelany 4, * and Ahmed Barhoum 5,6, * . Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue Engineering, Antimicrobial, and Agro-Food Applications. Nanomaterials 2022, 12 (3). https://doi.org/10.3390/nano12030457 (Impact Factor: 5.7).

8. Manish Gaur 1, Charu Misra 1, Awadh Bihari Yadav 1,* Shiv Swaroop 2, Fionn Ó Maolmhuaidh 3,Mikhael Bechelany 4,* and Ahmed Barhoum 5,*: Biomedical Applications of Carbon Nanomaterials: Fullerenes, Quantum Dots, Nanotubes, Nanofibers, and Graphene. Materials 2021, 14, x. https://doi.org/10.3390/xxxxx. (Impact Factor: 3.7).

9. Preeti Yadav, Awadh Bihari Yadav: Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system . Future Journal of Pharmaceutical Sciences, 2021 DOI : 10.1186/s43094-021-00345-w.(Impact Factor: 2.6)

10. Amit K. Singh, Rahul K. Verma, Jatinder Kaur Mukker, Awadh B. Yadav, Pavan Muttil, Rolee Sharma and Amit Misra; Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month. Tuberculosis, Volume 128, May 2021, 102081: https://doi.org/10.1016/j.tube.2021.102081 (Impact Factor: 2.9). 

11. Niti Singh, Preeti Yadav, Preksha Gaur, Manish Gaur, Awadh Bihari Yadav; Protein stability and functional activity during nebulization: A comparative study of three nebulizers!; bioRxiv (Preprint); doi: https://doi.org/10.1101/2020.05.09.085720.

12.  Ciara Kelly*, Awadh B Yadav*, Ciaran Lawlor, Katie Nolan, Joanne O’Dwyer, Catherine M Greene, Noel G McElvaney, Neeraj Sivadas, Joanne M Ramsey, Sally-Ann Cryan; Therapeutic Aerosol Bioengineering of siRNA for the Treatment of Inflammatory Lung Disease by TNFα Gene Silencing in Macrophages; Mol. Pharmaceutics, 2014, 11 (11), pp 4270–4279 (Equal contribution=*) (Impact Factor: 4.78)

13. Amit K Singh, Awadh Bihari Yadav, Rajiv Garg  and Amit Misra: Single-nucleotide polymorphic macrophage cytokine regulation by Mycobacterium tuberculosis and drug treatment Pharmacogenomics 2014: 15(4): 497-508 (Impact Factor: 3.97) 

14. JM Ramsey, C Kelly, AB Yadav, NG McElvaney, D Small, C Taggart, SA Cryan, Bioengineering of siRNA for treatment of inflammatory lung disease: journal of aerosol medicine and pulmonary drug delivery 26 (2), a14-a15. (Impact Factor: 2.79)

15.  Amit K Singh, Abhimanyu, Awadh B Yadav, Sandeep Sharma, Rajiv Garg, Mridula Bose and Amit Misra. HLA‑DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles Pharmacogenomics 2013: 14(5): 531-540 (Impact Factor: 3.97)

16. Awadh B Yadav; Amit K Singh; Rahul K Verma; Mradul Mohan; Atul K Agrawal;   Amit Misra, The Devil's Advocacy: When and Why Inhaled Therapies for Tuberculosis May Not Work. Tuberculosis (Edinb). 2011: 91(1): 65-6 (Impact Factor: 3.125).

17. Katie Nolan, Neeraj Sivadas, Ciara Kelly, Awadh Yadav, Tomas Carroll, Warren Thomas, Catherine Greene, Sally-Ann Cryan, Targeting z-alpha-1-antitrypsin siRNA to primary macrophages using inhalable, particulate technology. Irish journal of medical science: Volume: 179 Pages: S299-S299 Supplement: Suppl. 7 Published: AUG 2010 PMID: ISSN: 0021-1265. (Impact Factor: 0.827).

18. Yadav. A.B, Muttil. P, Singh. A.K, Verma. R.K, Mohan. M, Agrawal. A.K.,Verma. A.S, Sinha. S.K, and Amit Misra, Microparticles induce variable level of activation in macrophages infected with Mycobacterium tuberculosis. Tuberculosis (Edinb) 2010: 90: 188-196 (Impact Factor: 3.125)

19. A. B. Yadav, R.Sharma, P. Muttil, A. K. Singh, R. K. Verma, M. Mohan, S.K.Patel & Amit   Misra,, Inhalable microparticles containing isoniazid and rifabutin target macrophages and ‘stimulate the phagocyte’ to achieve high efficacy . Indian J Experimental Biol. 2009: 47: 469-74 (Impact Factor: 1.20)

20. J. Kaur, P. Muttil, R. Verma, K. Kumar, A. B. Yadav, R. Sharma, and A. Misra. Microparticles containing Antitubercular Drugs target Lung Macrophages on Administration to Mice using a Biosafe Inhalation Apparatus. European Journal of Pharmaceutical Sciences: 2008 10; 34 (1):56-65. (Impact Factor: 3.35).

21. R. K Verma; J. Kaur; K. Kumar; A. B. Yadav and A. Misra. Intracellular time-course, pharmacokinetics and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice. Antimicrobial Agents and Chemotherapy; 2008 52(9):3195-3201. (Impact Factor: 4.47).

22. P. Muttil, J. Kaur, K. Kumar, A. B. Yadav, R. Sharma and A. Misra. Inhalable Microparticles containing Large Payload of Anti-tuberculosis drugs. European Journal of Pharmaceutical Sciences: 32 (2007) 140–150. (Impact Factor: 3.35).

23. A. B. Yadav and A. Misra, Enhancement of Apoptosis of THP-1 Cells Infected with Mycobacterium tuberculosis by Inhalable Microparticles and Relevance to Bactericidal Activity. Antimicrobial Agents and Chemotherapy; 2007; 51(10):3740-3742. (Impact Factor: 4.47).

24. R. Sharma, P. Muttil, A. B. Yadav, S. K. Rath, V. K. Bajpai, U. Mani and A. Misra. Uptake of inhalable microparticles affects defense responses of macrophages infected with Mycobacterium tuberculosis H37Ra: J. Antimicrob. Chemother. 2007 59: 499-506. (Impact Factor: 5.31)

Book Chapters

1. Preparation and Optimization of Insulin Loaded Solid Lipid Nanoparticles for the Targeted Delivery of Insulin to the Lungs for Diabetes Treatment via Inhalation : Preeti Yadav, Awadh Bihari Yadav: Composite Materials for Extreme Loading: 2021; DOI : 10.1007/978-981-16-4138-1 

2. Carbon-Based Nanofibers: Fullerenes, Diamond, and Carbon Nanostructures: R K Verma, Charu Misra, Awadh Bihari Yadav: Handbook of Nanofibers: 2018; https://doi.org/10.1007/978-3-319-42789-8_5-1

3. DNA nanostructures: chemistry, self-assembly, and applications: A Sharma, K Vaghasiya, RK Verma, AB Yadav: Emerging Applications of Nanoparticles and Architecture Nanostructures;2018: 71-94

4. RNAi for respiratory diseases: Ciara Kelly, Awadh B Yadav, Sally-Ann Cryan: Advanced Delivery and Therapeutic Applications of RNAi, 391-416. Press 2014.

5. Research articles “HLA-DRB1*1501 and VDR polymorphisms and survival of Mcobacterium tuberculosis in human macrophages exposed to inhalable microparticles" (published in "Pharmacogenomics.2013Apr; 14(5):531-540.") selected to be featured in World Biomedical Frontiers, because of its innovation and potential to improve health or to treat or prevent disease. (http://biomedfrontiers.org/infection-2013-10-51/ ), in the section of Infection and Immunity.)

Invited Speakers

1. Invited lecture on topic “Targeted therapy for lungs disease treatment via inhalation route” a Workshop organised by Department of Biotechnology, MNNIT, Allahabad on 26th March, 2014. 

2. Invited Speaker on the topic “Therapeutic Aerosol of Microparticles for Targeted Delivery of Anti-inflammatory siRNA to the Lungs Macrophages” in International Conference Biosangam-2016 organized by MNNIT Allahabad on 6th Feb 2016. 

3. Invited Speaker on the topic “Functional Activity and Stability of the Therapeutics Protein after Nebulization for Targeted Delivery to the Lungs” in National conference Convergence of Pharmaceutical Sciences and Biomedical Technology (CPSBT-2018) organized by NIPER Ahmedabad between 21st to 23rd  March 2018.

4. Invited Speaker on the topic “Fabrication of Biodegradable Sanitary Napkin:  A Step toward Social Upliftment & Women Empowerment in the Rural Area” in National conference Convergence of Pharmaceutical Sciences and Biomedical Technology (CPSBT-2018) organized by NIPER Ahmedabad between 21st to 23rd  March 2018.

5. Invited Speaker on the topic "COVID-19 Diagnosis, Challenges and Opportunity" at international webinar (e-conference) on Prospective of Interdisciplinary Research in Science and Technology in the Present Scenario organized by CCS University Meerut, India on 15-16 May 2020.    

6. Invited Speaker  on the topic "Targeted Delivery of siRNA loaded Micro and Nano carriers for the treatments of lung inflammation and lung cancer"  2 Days Workshop  on Nano and Micro formulations as drug delivery system by Integral University Lucknow, India on 9 th to 10 th March 2021.

7. Invited Speaker and delivered talk on 6th December 2021 on  the topic "siRNA as a future therapy for lungs disease" on "Future prospects of Molecular Technologies in Biological Research" from 23rd Nov to 8th Dec 2021 in a professional development program (PDP) organized by Integral University Lucknow.

Poster Published

1. Yadav, Awadh Bihari and Misra, Amit. Tumor necrosis factor and caspase in response to soluble or microparticle-incorporated drugs in Mycobacterium tuberculosis infection. Available from Nature Precedings: <http://dx.doi.org/10.1038/npre.2007.1190.1> (2007).

2. Yadav, Awadh Bihari, Singh, Amit K., and Misra, Amit. Genome-wide transcription analysis of interaction between the human macrophage and Mycobacterium tuberculosis during concurrent drug administration by conventional and novel methods. Available from Nature Precedings: <http://dx.doi.org/10.1038/npre.2008.2453.1> (2008).

3. Verma, Rahul Kumar, Kaur, Jatinder, Yadav, Awadh Bihari, Kumar, Kauslender, and Misra, Amit. PLA Microparticles for Pulmonary Delivery of AntiTB drugs: Biodistribution study. Available from Nature Precedings: <http://dx.doi.org/10.1038/npre.2008.2448.1> (2008).